LOSS PER SHARE AND STOCKHOLDERS’ EQUITY:

3 Months Ended

Jun. 30, 2019

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

LOSS PER SHARE AND STOCKHOLDERS' EQUITY:

LOSS PER SHARE AND STOCKHOLDERS’ EQUITY:

Loss Per Share

A reconciliation of the numerator and denominator of basic and diluted loss per share is shown below (in thousands, except per share amounts): 

	For the three months ended
	June 30,
	2019		2018
Basic loss per share:
Net loss from continuing operations	$	(42,140)	$	(27,818)
Earnings from discontinued operations, net of tax	—		24,803
Net loss	$	(42,140)	$	(3,015)
Basic weighted-average shares outstanding	68,906		76,935
Continuing operations	$	(0.61)	$	(0.36)
Discontinued operations	—		0.32
Basic loss per share	$	(0.61)	$	(0.04)
Diluted loss per share:
Basic weighted-average shares outstanding	68,906		76,935
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	—		—
Diluted weighted-average shares outstanding	68,906		76,935
Continuing operations	$	(0.61)	$	(0.36)
Discontinued operations	—		0.32
Diluted loss per share	$	(0.61)	$	(0.04)

Due to the net loss from continuing operations during the three months ended June 30, 2019 and 2018, the dilutive effect of options and restricted stock units covering 2.8 million and 2.3 million shares of common stock, respectively was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive.

Additional options to purchase shares of common stock and restricted stock units that were outstanding during the periods presented but were not included in the computation of diluted loss per share because the effect was anti-dilutive are shown below (shares in thousands): 

	For the three months ended
	June 30,
	2019	2018
Number of shares outstanding under options, warrants and restricted stock units plans	431	119
Range of exercise prices for options	N/A	$	32.85

Stockholders’ Equity

Under the modified common stock repurchase program, the Company may purchase up to $1.0 billion of its common stock through the period ending December 31, 2020. During the three months ended June 30, 2019, the Company repurchased 0.4 million shares of its common stock for $20.1 million under the stock repurchase

program.  Through June 30, 2019, the Company had repurchased a total of 23.0 million shares of its stock for $469.2 million under the stock repurchase program, leaving remaining capacity of $530.8 million.

Accumulated other comprehensive income accumulated balances of $7.3 million and $7.8 million at June 30, 2019 and March 31, 2019, respectively, reflect accumulated foreign currency translation adjustments.